The WACC of Asarina Pharma AB (publ) (ASAP.ST) is 7.1%.
| Range | Selected | |
| Cost of equity | 7.50% - 12.60% | 10.05% |
| Tax rate | 10.20% - 11.10% | 10.65% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.9% - 8.4% | 7.1% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.98 | 1.49 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.50% | 12.60% |
| Tax rate | 10.20% | 11.10% |
| Debt/Equity ratio | 1.09 | 1.09 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.9% | 8.4% |
| Selected WACC | 7.1% | |